Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study

Nicholas D Giardino, Jeffrey L Curtis, Adin-Cristian Andrei, Vincent S Fan, Joshua O Benditt, Mark Lyubkin, Keith Naunheim, Gerard Criner, Barry Make, Robert A Wise, Susan K Murray, Alfred P Fishman, Frank C Sciurba, Israel Liberzon, Fernando J Martinez, NETT Research Group

Abstract

Background: Anxiety in patients with chronic obstructive pulmonary disease (COPD) is associated with self-reported disability. The purpose of this study is to determine whether there is an association between anxiety and functional measures, quality of life and dyspnea.

Methods: Data from 1828 patients with moderate to severe emphysema enrolled in the National Emphysema Treatment Trial (NETT), collected prior to rehabilitation and randomization, were used in linear regression models to test the association between anxiety symptoms, measured by the Spielberger State Trait Anxiety Inventory (STAI) and: (a) six-minute walk distance test (6 MWD), (b) cycle ergometry peak workload, (c) St. Georges Respiratory Questionnaire (SRGQ), and (d) UCSD Shortness of Breath Questionnaire (SOBQ), after controlling for potential confounders including age, gender, FEV1 (% predicted), DLCO (% predicted), and the Beck Depression Inventory (BDI).

Results: Anxiety was significantly associated with worse functional capacity [6 MWD (B = -0.944, p < .001), ergometry peak workload (B = -.087, p = .04)], quality of life (B = .172, p < .001) and shortness of breath (B = .180, p < .001). Regression coefficients show that a 10 point increase in anxiety score is associated with a mean decrease in 6 MWD of 9 meters, a 1 Watt decrease in peak exercise workload, and an increase of almost 2 points on both the SGRQ and SOBQ.

Conclusion: In clinically stable patients with moderate to severe emphysema, anxiety is associated with worse exercise performance, quality of life and shortness of breath, after accounting for the influence of demographic and physiologic factors known to affect these outcomes.

Trial registration: ClinicalTrials.gov NCT00000606.

References

    1. Prigatano GP, Wright EC, Levin D. Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. Arch Intern Med. 1984;144:1613–1619. doi: 10.1001/archinte.144.8.1613.
    1. Monso E, Fiz JM, Izquierdo J, Alonso J, Coll R, Rosell A, Morera J. Quality of life in severe chronic obstructive pulmonary disease: correlation with lung and muscle function. Respir Med. 1998;92:221–227. doi: 10.1016/S0954-6111(98)90099-3.
    1. McSweeny AJ, Grant I, Heaton RK, Adams KM, Timms RM. Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med. 1982;142:473–478. doi: 10.1001/archinte.142.3.473.
    1. Felker B, Katon W, Hedrick SC, Rasmussen J, McKnight K, McDonnell MB, Fihn SD. The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry. 2001;23:56–61. doi: 10.1016/S0163-8343(01)00127-X.
    1. Cully JA, Graham DP, Stanley MA, Ferguson CJ, Sharafkhaneh A, Souchek J, Kunik ME. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics. 2006;47:312–319. doi: 10.1176/appi.psy.47.4.312.
    1. Beck JG, Scott SK, Teague RB, Perez FI. Correlates of daily impairment in COPD. Rehabil Psychol. 1988;33:77–84.
    1. Kim HF, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, Petersen NJ, Nahas Z, Goodnight-White S. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics. 2000;41:465–471. doi: 10.1176/appi.psy.41.6.465.
    1. Dahlen I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest. 2002;122:1633–1637. doi: 10.1378/chest.122.5.1633.
    1. Borak J, Chodosowska E, Matuszewski A, Zielinski J. Emotional status does not alter exercise tolerance in patients with chronic obstructive pulmonary disease. Eur Respir J. 1998;12:370–373.
    1. Engstrom CP, Persson LO, Larsson S, Ryden A, Sullivan M. Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: a descriptive and comparative study. Thorax. 1996;51:825–830. doi: 10.1136/thx.51.8.825.
    1. Withers NJ, Rudkin ST, White RJ. Anxiety and depression in severe chronic obstructive pulmonary disease: the effects of pulmonary rehabilitation. J Cardiopulm Rehabil. 1999;19:362–365. doi: 10.1097/00008483-199911000-00007.
    1. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry. 2000;15:1090–1096. doi: 10.1002/1099-1166(200012)15:12<1090::AID-GPS249>;2-L.
    1. Kvaal K, Macijauskiene J, Engedal K, Laake K. High prevalence of anxiety symptoms in hospitalized geriatric patients. Int J Geriatr Psychiatry. 2001;16:690–693. doi: 10.1002/gps.405.
    1. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006;31:58–69. doi: 10.1016/j.jpainsymman.2005.06.007.
    1. Karajgi B, Rifkin A, Doddi S, Kolli R. The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. Am J Psychiatry. 1990;147:200–201.
    1. Moore MC, Zebb BJ. The catastrophic misinterpretation of physiological distress. Behaviour Research and Therapy. 1999;37:1105–1118. doi: 10.1016/S0005-7967(98)00197-1.
    1. Yellowlees PM, Haynes S, Potts N, Ruffin RE. Psychiatric morbidity in patients with life-threatening asthma: initial report of a controlled study. Med J Aust. 1988;149:246–249.
    1. Watson D, Pennebaker JW. Health complaints, stress, and distress: exploring the central role of negative affectivity. Psychol Rev. 1989;96:234–254. doi: 10.1037/0033-295X.96.2.234.
    1. Rationale and design of The National Emphysema Treatment Trial: a prospective randomized trial of lung volume reduction surgery. The National Emphysema Treatment Trial Research Group. Chest. 1999;116:1750–1761. doi: 10.1378/chest.116.6.1750.
    1. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348:2059–2073. doi: 10.1056/NEJMoa030287.
    1. Speilberger CD. Manual for the State-Trait Anxiety Inventory. Palo Alto, California: Consulting Psychologists Press; 1983.
    1. Kellner R, Uhlenhuth EH. The rating and self-rating of anxiety. The British journal of psychiatry. 1991. pp. 15–22.
    1. Beck AT, Steer RA. Beck Depression Inventory, Revised Edition (BDI) San Antonio, TX: The Psychological Corporation; 1971.
    1. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992;145:1321–1327.
    1. Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM. Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest. 1998;113:619–624. doi: 10.1378/chest.113.3.619.
    1. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152:1107–1136.
    1. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update. Am J Respir Crit Care Med. 1995;152:2185–2198.
    1. Crapo RO, Morris AH. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis. 1981;123:185–189.
    1. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis. 1981;123:659–664.
    1. Sciurba F, Criner GJ, Lee SM, Mohsenifar Z, Shade D, Slivka W, Wise RA. Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med. 2003;167:1522–1527. doi: 10.1164/rccm.200203-166OC.
    1. Himmelfarb S, Murrell SA. The prevalence and correlates of anxiety symptoms in older adults. J Psychol. 1984;116:159–167.
    1. Murrell SA, Himmelfarb S, Wright K. Prevalence of depression and its correlates in older adults. Am J Epidemiol. 1983;117:173–185.
    1. Cohen-Cole SA, Stoudemire A. Major depression and physical illness. Special considerations in diagnosis and biologic treatment. Psychiatr Clin North Am. 1987;10:1–17.
    1. Cavanaugh S, Clark DC, Gibbons RD. Diagnosing depression in the hospitalized medically ill. Psychosomatics. 1983;24:809–815.
    1. Ferrer M, Villasante C, Alonso J, Sobradillo V, Gabriel R, Vilagut G, Masa JF, Viejo JL, Jimenez-Ruiz CA, Miravitlles M. Interpretation of quality of life scores from the St George's Respiratory Questionnaire. Eur Respir J. 2002;19:405–413. doi: 10.1183/09031936.02.00213202.
    1. Steffen TM, Hacker TA, Mollinger L. Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds. Phys Ther. 2002;82:128–137.
    1. von Leupoldt A, Ambruzsova R, Nordmeyer S, Jeske N, Dahme B. Sensory and affective aspects of dyspnea contribute differentially to the Borg scale's measurement of dyspnea. Respiration. 2006;73:762–768.
    1. Carrieri-Kohlman V, Gormley JM, Douglas MK, Paul SM, Stulbarg MS. Differentiation between dyspnea and its affective components. Western journal of nursing research. 1996;18:626–642. doi: 10.1177/019394599601800602.
    1. Giardino ND, Chan L, Borson S. Combined heart rate variability and pulse oximetry biofeedback for chronic obstructive pulmonary disease: preliminary findings. Appl Psychophysiol Biofeedback. 2004;29:121–133. doi: 10.1023/B:APBI.0000026638.64386.89.
    1. Aydin IO, Ulusahin A. Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Gen Hosp Psychiatry. 2001;23:77–83. doi: 10.1016/S0163-8343(01)00116-5.
    1. Beck JG, Scott SK, Teague RB, Perez FI. et al.Correlates of daily impairment in COPD. Rehabil Psychol. 1988;33:77–84.
    1. Gudmundsson G, Gislason T, Janson C, Lindberg E, Suppli Ulrik C, Brondum E, Nieminen MM, Aine T, Hallin R, Bakke P. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med. 2006;100:87–93. doi: 10.1016/j.rmed.2005.04.003.
    1. Weaver TE, Richmond TS, Narsavage GL. An explanatory model of functional status in chronic obstructive pulmonary disease. Nurs Res. 1997;46:26–31. doi: 10.1097/00006199-199701000-00005.
    1. Fan VS, Ramsey SD, Giardino ND, Make BJ, Emery CF, Diaz PT, Benditt JO, Mosenifar Z, McKenna R Jr, Curtis JL. et al.Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med. 2007;167:2345–2353. doi: 10.1001/archinte.167.21.2345.
    1. Martinez FJ, Curtis JL, Sciurba F, Mumford J, Giardino ND, Weinmann G, Kazerooni E, Murray S, Criner GJ, Sin DD. et al.Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med. 2007;176:243–252. doi: 10.1164/rccm.200606-828OC.
    1. Isoaho R, Keistinen T, Laippala P, Kivela SL. Chronic obstructive pulmonary disease and symptoms related to depression in elderly persons. Psychol Rep. 1995;76:287–297.
    1. de Torres JP, Casanova C, Hernandez C, Abreu J, Aguirre-Jaime A, Celli BR. Gender and COPD in patients attending a pulmonary clinic. Chest. 2005;128:2012–2016. doi: 10.1378/chest.128.4.2012.
    1. Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, Allegra L, Centanni S. Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med. 2006;100:1767–1774. doi: 10.1016/j.rmed.2006.01.026.
    1. Stahl E, Lindberg A, Jansson SA, Ronmark E, Svensson K, Andersson F, Lofdahl CG, Lundback B. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes. 2005;3:56. doi: 10.1186/1477-7525-3-56.
    1. Neuman A, Gunnbjornsdottir M, Tunsater A, Nystrom L, Franklin KA, Norrman E, Janson C. Dyspnea in relation to symptoms of anxiety and depression: A prospective population study. Respir Med. 2006;100:1843–1849. doi: 10.1016/j.rmed.2006.01.016.
    1. Porzelius J, Vest M, Nochomovitz M. Respiratory function, cognitions, and panic in chronic obstructive pulmonary patients. Behav Res Ther. 1992;30:75–77. doi: 10.1016/0005-7967(92)90101-L.
    1. Giardino ND, Borson S, Von Korff M, Chan L. Beliefs about breathlessness are associated with disability in COPD. American Thoracic Society annual meeting, May 2004; Orlando, FL.
    1. Shekhar A, Sajdyk TJ, Gehlert DR, Rainnie DG. The amygdala, panic disorder, and cardiovascular responses. Ann N Y Acad Sci. 2003;985:308–325.
    1. Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med. 2006;119:21–31. doi: 10.1016/j.amjmed.2006.08.004.
    1. Means-Christensen AJ, Sherbourne CD, Roy-Byrne PP, Craske MG, Stein MB. Using five questions to screen for five common mental disorders in primary care: diagnostic accuracy of the Anxiety and Depression Detector. Gen Hosp Psychiatry. 2006;28:108–118. doi: 10.1016/j.genhosppsych.2005.08.010.
    1. Borson S, McDonald GJ, Gayle T, Deffebach M, Lakshminarayan S, VanTuinen C. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics. 1992;33:190–201.
    1. Argyropoulou P, Patakas D, Koukou A, Vasiliadis P, Georgopoulos D. Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. Respiration. 1993;60:216–220. doi: 10.1159/000196202.
    1. Papp LA, Weiss JR, Greenberg HE, Rifkin A, Scharf SM, Gorman JM, Klein DF. Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders. Am J Psychiatry. 1995;152:1531.
    1. Smoller JW, Pollack MH, Systrom D, Kradin RL. Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics. 1998;39:24–29.
    1. Kunik ME, Braun U, Stanley MA, Wristers K, Molinari V, Stoebner D, Orengo CA. One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med. 2001;31:717–723. doi: 10.1017/S0033291701003890.
    1. de Godoy DV, de Godoy RF. A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2003;84:1154–1157. doi: 10.1016/S0003-9993(03)00239-9.
    1. Emery CF. Effects of age on physiological and psychological functioning among COPD patients in an exercise program. J Aging Health. 1994;6:3–16. doi: 10.1177/089826439400600101.
    1. Emery CF, Schein RL, Hauck ER, MacIntyre NR. Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol. 1998;17:232–240. doi: 10.1037/0278-6133.17.3.232.
    1. Emery CF, Shermer RL, Hauck ER, Hsiao ET, MacIntyre NR. Cognitive and psychological outcomes of exercise in a 1-year follow-up study of patients with chronic obstructive pulmonary disease. Health Psychol. 2003;22:598–604. doi: 10.1037/0278-6133.22.6.598.
    1. Guell R, Resqueti V, Sangenis M, Morante F, Martorell B, Casan P, Guyatt GH. Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest. 2006;129:899–904. doi: 10.1378/chest.129.4.899.
    1. Kayahan B, Karapolat H, Atyntoprak E, Atasever A, Ozturk O. Psychological outcomes of an outpatient pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease. Respir Med. 2006;100:1050–1057. doi: 10.1016/j.rmed.2005.09.031.
    1. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe